Acupoint Application in Patients With Stable Angina Pectoris (AASAP)

Sponsor
Chengdu University of Traditional Chinese Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT02029118
Collaborator
(none)
200
1
4
34
5.9

Study Details

Study Description

Brief Summary

Hypothesis: acupoint application is effective for managing chronic stable angina pectoris. Aim: to evaluate the efficacy and safety of acupoint application on the specific acupoints for chronic stable angina pectoris. Design: A Randomized, Controlled,Double Blind trial. 200 participants will be included. Four arms: herbal medicine application on acupoint group , placebo application on acupoint group , herbal medicine application on non-acupoint group and placebo application on non-acupoint group.

Condition or Disease Intervention/Treatment Phase
  • Drug: Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech)
  • Device: acupoint
  • Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
Early Phase 1

Detailed Description

Acupoint application with herbal medicine is a kind of external treatment of traditional Chinese medicine and has a long history in China, which is use herbal medicine made of plaster and stick to specific acupoints, using the double effects of acupoints and herb to treat disease. In China, acupoint application with herbal medicine has been used in clinical treatment of angina pectoris, but there is no convincing evidence for the efficacy of acupoint application for angina pectoris, due to low methodologic quality and small sample size. The investigators designed the Randomized, Controlled, Double Blind clinical trial to investigates the efficacy of acupoint application in treating angina pectoris, the purpose of this study is to provide the convincing evidence for acupoint application treatment of angina pectoris.

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effect of Acupoint Application With Herbal Medicine in Patients With Stable Angina Pectoris: Randomized, Controlled,Double Blind Clinical Study
Study Start Date :
Oct 1, 2012
Actual Primary Completion Date :
May 1, 2015
Actual Study Completion Date :
Aug 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Herbal application on acupoint group

Containing the herbal medicine application on the specific acupoints plus foundation treatment

Drug: Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech)
Application containing herbal medicine that mainly include styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech and other herbal medicine.
Other Names:
  • Herbal medicine application
  • Device: acupoint
    select acupoint according to traditional Chinese medicine
    Other Names:
  • acupuncture point
  • Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
    foundation treatment
    Other Names:
  • basic treatment
  • Placebo Comparator: Placebo application on acupoint

    Not containing herbal medicine application on the specific acupoints plus foundation treatment

    Device: acupoint
    select acupoint according to traditional Chinese medicine
    Other Names:
  • acupuncture point
  • Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
    foundation treatment
    Other Names:
  • basic treatment
  • Placebo Comparator: Herbal application on non-acupoint group

    Containing the herbal medicine application on the non-acupoints plus foundation treatment

    Drug: Herbal plaster ( styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech)
    Application containing herbal medicine that mainly include styrax, borneol, frankincense, santalum,trichosanthes kirilowii Maxim, allium macrostemon Bunge, leech and other herbal medicine.
    Other Names:
  • Herbal medicine application
  • Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
    foundation treatment
    Other Names:
  • basic treatment
  • Sham Comparator: Placebo application on non-acupoint

    Not containing herbal medicine application on the non-acupoints plus foundation treatment

    Drug: Aspirin: 100mg qd; Metoprolol:25mg bid; Ramipril:5mg qd; Atorvastatin:20mg qn.
    foundation treatment
    Other Names:
  • basic treatment
  • Outcome Measures

    Primary Outcome Measures

    1. Change from Baseline Number of angina attacks at 12 weeks [at baseline,4, 8weeks after inclusion]

      The change frequency of angina attack during every 4-week.

    Secondary Outcome Measures

    1. Change from Baseline the severity of angina ( VAS score) at 12 weeks [at baseline,4, 8weeks after inclusion]

      The VAS score evaluation angina pain severity

    2. Change from Baseline the dosage of nitroglycerin at 12 weeks [at baseline,4, 8weeks after inclusion]

      Observed reduction in the dose of nitroglycerin

    3. Seattle Angina Questionnaire [at baseline,4, 8weeks after inclusion]

    4. self-rating anxiety scale [at baseline,4, 8weeks after inclusion]

    5. Self-rating Depression Scale [at baseline,4, 8weeks after inclusion]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    35 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1.Meet the diagnostic criteria of American College of Cardiology(ACC)/American Heart Association (AHA) angina pectoris of coronary heart disease.

    2.35 ≤ age ≤ 85 years, both male and female.

    3.The onset of angina pectoris≥3 months, and the frequency of angina attack≥2 a week.

    4.Patients signed the informed consent

    Exclusion Criteria:
    1. age≤35 or age≥85.

    2. Pregnant women or women in lactation or women of child bearing potential plan to conceive in the recent six months.

    3. history of diabetes.

    4. Co-infection or bleeding, allergic.

    5. Currently participating in other clinical trials

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Affiliated hospital of Chengdu University of TCM Chengdu Sichuan China 610072

    Sponsors and Collaborators

    • Chengdu University of Traditional Chinese Medicine

    Investigators

    • Principal Investigator: Fanrong Liang, Chengdu University of TCM

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Chengdu University of Traditional Chinese Medicine
    ClinicalTrials.gov Identifier:
    NCT02029118
    Other Study ID Numbers:
    • 2011SZ0302.2
    First Posted:
    Jan 7, 2014
    Last Update Posted:
    Feb 17, 2020
    Last Verified:
    Feb 1, 2020
    Keywords provided by Chengdu University of Traditional Chinese Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 17, 2020